Sartorius | SRT3 - Current Assets

Stock Price
217.10
Daily Change
2.20 1.02%
Monthly
0.74%
Yearly
-3.12%
Q2 Forecast
211.39

Sartorius reported EUR1.92B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Akebia Therapeutics USD 252.96M 5.38M Dec/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Avita Medical AUD 35.49M 760K Dec/2025
Dianthus Therapeutics USD 409.44M 4.39M Dec/2025
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Moderna USD 6.54B 54M Dec/2025
Organon & Co USD 4.7B 82M Sep/2025
Revvity USD 2.24B 95.96M Dec/2025
Sartorius EUR 1.92B 157.2M Mar/2026
Tectonic Therapeutic USD 257.36M 15.88M Dec/2025
Viatris USD 9.79B 162.2M Dec/2025
Xeris Pharmaceuticals USD 240.31M 16.3M Dec/2025